ACONW Aclarion, Inc.

Healthcare [ 2/11 ] | Health Information Services [ 49/156 ]

US | NASDAQ | Stock

Price: $0.0785

Increased by 0.00%
Dollar Volume: 541.85
ADR%: 24.74

Market Cap.: 0.00
Shares Float: N/A
Shares Outstanding: N/A

Beta: 0.00
Price / Earnings: -0.01
BPR: 3.64

20D Range: 0.06 0.22
50D Range: 0.06 0.31
200D Range: 0.06 0.75

Quarterly Earnings
Annual Earnings

Reported Date	EPSChange YoY	EstimateSurprise

Quarterly Financials
Annual Financials

Fiscal ending date	RevenueChange YoY	IncomeChange YoY	ProfitChange YoY
Sep 30, 22	18.22 K Increased by +67.71%	-1.63 M Decreased by -96.71%	Decreased by -8.96 K% Decreased by -17.29%
Jun 30, 22	10.68 K Decreased by -58.33%	-3.71 M Decreased by -695.87%	Decreased by -34.73 K% Decreased by -1.81 K%
Mar 31, 22	9.03 K Decreased by -23.70%	-936.09 K Decreased by -80.76%	Decreased by -10.37 K% Decreased by -136.92%
Dec 31, 21	11.98 K Increased by +20.11%	-3.14 M Decreased by -517.98%	Decreased by -26.19 K% Decreased by -414.53%
Sep 30, 21	10.87 K -	-830.18 K -	Decreased by -7.64 K% -
Jun 30, 21	25.62 K -	-465.84 K -	Decreased by -1.82 K% -
Mar 31, 21	11.83 K -	-517.86 K -	Decreased by -4.38 K% -
Dec 31, 20	9.97 K -	-507.52 K -	Decreased by -5.09 K% -

Top 20 ETF Stock Exposure
Top 20 Institutional Holders
Top 20 Mutual Fund Holders

Rank	ETF	Shares	Market Value	Weight % in ETF

DAILY

WEEKLY

MONTHLY

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.